67 results
Page 2 of 4
8-K
b2ck0uqv jwlzf
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.2
3zu4dq1a 8r3gkt
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
y5pi6kb
22 Jun 20
VBI Vaccines Announces Results of Annual General Meeting
12:45pm
8-K
EX-1.1
xk0ev84 8467i
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
424B5
ul72ytx0dl8qh
21 Apr 20
Prospectus supplement for primary offering
4:18pm
424B5
gyoqhsx56zr2 byfbzy
20 Sep 19
Prospectus supplement for primary offering
5:28pm
8-K
EX-1.1
324eb
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm
424B5
eaics
18 Sep 19
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.2
rmnzdfhd e3x
17 Jun 19
Regulation FD Disclosure
7:59am
8-K
z3uqksowyv9rvmyy2
14 Jun 19
VBI Vaccines Announces Results of Annual General Meeting
6:05am
424B5
596 kf7w0vl7jk
17 Dec 18
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
dzqc07m32i13sp w8c
17 Dec 18
VBI Vaccines Announces Proposed Public Offering of Common Shares
12:00am
424B5
50um9p bzyn
12 Dec 18
Prospectus supplement for primary offering
4:17pm
8-K
209vs mvwa44
29 May 18
VBI Vaccines Announces Results of Annual General Meeting
10:59am